Pre-Emptive Pharmacogenetic Testing in Clinical Practice

被引：0
作者：
Swen, Jesse J. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2022年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
E06.1
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
[1]   Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing [J].
Duarte, Julio D. ;
Dalton, Rachel ;
Elchynski, Amanda L. ;
Smith, D. Max ;
Cicali, Emily J. ;
Lee, James C. ;
Duong, Benjamin Q. ;
Petry, Natasha J. ;
Aquilante, Christina L. ;
Beitelshees, Amber L. ;
Empey, Philip E. ;
Johnson, Julie A. ;
Obeng, Aniwaa Owusu ;
Pasternak, Amy L. ;
Pratt, Victoria M. ;
Ramsey, Laura B. ;
Tuteja, Sony ;
Van Driest, Sara L. ;
Wiisanen, Kristin ;
Hicks, J. Kevin ;
Cavallari, Larisa H. .
GENETICS IN MEDICINE, 2021, 23 (12) :2335-2341
[2]   Clinical use of pre-emptive pharmacogenetic programmes [J].
Penas-LLedo, Eva ;
LLerena, Adrian .
LANCET, 2023, 401 (10374) :320-321
[3]   Implementing pre-emptive pharmacogenetic screening into clinical routine [J].
Forsstrom, J. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 :S85-S85
[4]   Temporary Like Achilles: Pre-emptive germline pharmacogenetic testing [J].
Damkier, Per ;
Andersen, Michael Asger .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (04) :397-399
[5]   Reply to: Temporary Like Achilles: Pre-emptive germline pharmacogenetic testing [J].
Guchelaar, Henk-Jan ;
Swen, Jesse .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 133 (04) :400-401
[6]   A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program [J].
Schildcrout, Jonathan S. ;
Shi, Yaping ;
Danciu, Ioana ;
Bowton, Erica ;
Field, Julie R. ;
Pulley, Jill M. ;
Basford, Melissa A. ;
Gregg, William ;
Cowan, James D. ;
Harrell, Frank E., Jr. ;
Roden, Dan M. ;
Peterson, Josh F. ;
Denny, Joshua C. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 72 :107-115
[7]   The Case for Pre-Emptive Pharmacogenetic Screening in South Africa [J].
Hurrell, Tracey ;
Naidoo, Jerolen ;
Masimirembwa, Collen ;
Scholefield, Janine .
JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01)
[8]   Obviously nine believers: Actionable germline genetic variants for pre-emptive pharmacogenetic testing [J].
Damkier, Per .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (01) :5-6
[9]   Estimation of Impact of Implementing Pre-emptive Pharmacogenetic Testing in Hospital Treated Patients in Finland [J].
Kulla, N. ;
Cajanus, K. ;
Kyto, V ;
Niemi, M. ;
Tornio, A. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) :S101-S101
[10]   Pre-emptive pharmacogenetic testing in the acute hospital setting: a cross-sectional study [J].
McDermott, John H. ;
Burke, Kerry ;
Fullerton, Neil ;
O'Sullivan, James ;
Alex, Aleina ;
Ingham, Amy ;
Sharma, Videha ;
Godfrey, Nicola ;
Odudu, Aghogho ;
Syed, Tania ;
Stevens, Andrew ;
Beynon, Rhys ;
Greaves, Nicholas ;
Akam, Daniel ;
Mirza, Selman ;
Wilson, Paul ;
Wright, Stuart ;
Payne, Katherine ;
Newman, William G. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2025, 118 (03) :154-160
12345